A primer of bone metastases management in breast cancer patients
Bone is the most common site for distant spread of breast cancer. Following a diagnosis of metastatic bone disease, patients can suffer from significant morbidity because of pain and skeletal related events (sres). Bisphosphonates are potent inhibitors of osteoclastic function and the mainstay of bo...
Main Authors: | Petrut, B., Trinkaus, M., Simmons, C., Clemons, M. |
---|---|
Format: | Online |
Language: | English |
Published: |
Multimed Inc.
2008
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2216426/ |
Similar Items
-
Bone-Targeted Agents for the Management of Breast Cancer Patients with Bone Metastases
by: Simos, Demetrios, et al.
Published: (2013) -
Does confirmatory tumor biopsy alter the management of breast cancer patients with distant metastases?
by: Simmons, C., et al.
Published: (2009) -
Incidence, consequences and treatment of bone metastases in breast cancer patients—Experience from a single cancer centre
by: Kuchuk, I., et al.
Published: (2013) -
Incidence and consequences of bone metastases in lung cancer patients
by: Kuchuk, Michael, et al.
Published: (2013) -
A systematic review of dosing frequency with bone-targeted agents for patients with bone metastases from breast cancer
by: Hutton, Brian, et al.
Published: (2013)